Delivery Order SPE2DB20D7066-SPE2DB26FC1NR
- Not listed
- The Defense Logistics Agency awarded a $1,154.95 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml) pharmaceutical product, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $5,061.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This is a non-set-aside competitive award with an ultimate completion date of December 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest procurement action within the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units at a firm fixed price of $4,058.09. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The work is...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units, with a contract ceiling value of $6,988.89. This is a firm fixed price delivery order with an ultimate completion date of October 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2025, for the supply of Ropivacaine 0.2% 200 mg/100 mL in 100 mL vials, with a ceiling value of $1,241.69. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units) at a ceiling value of $1,431.54. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is performed out of the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml units, with a ceiling value of $2,147.31. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency awarded a delivery order valued at $2,162.46 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,571.85 to AmerisourceBergen Drug Corp for Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1NRDelivery Order
The Defense Logistics Agency awarded a $5,112.84 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% 200 mg/100 mL in 100 mL quantities. This delivery order represents a firm fixed price contract with no set-aside designation, utilizing open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive IDC with DLA functions as a comprehensive global pharmaceutical support vehicle, enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order for the local anesthetic Ropivacaine reflects the company's ongoing role in fulfilling federal medical supply requirements across multiple therapeutic domains through the DLA Troop Support Medical contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 11/4/25 |